Hepatitis B adjuvanted vaccine
Phase 3Vaccine
GSKHepatitis B adjuvanted vaccine is one of 53 biologic programs targeting Cervical Intraepithelial Neoplasia. It is currently in Phase 3.
2
Indications
5
Total Trials
0
Active Trials
52
Competitors
Pipeline
Status by Indication[3][1]
Competition
Competitive Landscape
252 competitors in Hepatitis B
#DrugCompanyPhaseTrials
1Viread
GileadPhase 3
Hepatitis B Vaccine
SanofiPhase 3
YF-Vax
SanofiPhase 3
Virazole
CConrado Roberto Hoffmann Filho
Phase 3
Immunoglobulins
CSL BehringPhase 3
Recombinant Hepatitis B Vaccine
NovartisPhase 3
Hydronidone
BBeijing Continent Pharmaceutical Co, Ltd.
Phase 3
B/F/TAF
GileadPhase 3
Polio Sabin.
GSKPhase 3
Hepatitis B adjuvanted vaccine
GSKPhase 3
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Trials by Indication[1]
Hepatitis B4 trials
Sources
References
- [1]
- [2]
- [3]
- [4]